Pershing Square’s Ackman Makes Unorthodox Alliance to Buy Allergan – AGN

Shares of specialty pharmaceutical company Allergan, Inc. (AGN) are up 30 points, or 21%, at $171 and change in the premarket hours session, after The Wall Street Journal reported that activist investor Bill Ackman is partnering with Valeant Pharmaceuticals Int’l (VRX) in an effort to takeover Allergan, the maker of cosmetology blockbuster Botox. In a 13-D securities […] View the full post at: Pershing Square’s Ackman Makes Unorthodox Alliance to Buy Allergan – AGN Related posts: Allergan Gets FDA Approval: Botox Has a Medical Use?! Target Hits the Bull’s Eye in the Second Quarter Regulators Trying to Forge a Main Street, Wall Street Alliance